Antibodies to vascular heparan sulfate proteoglycan in patients with systemic lupus Erythematosus

References

• Klemperer PAD, Baehr G. Diffuse collagen disease. J. Amer Med Assoc 1942; 119: 331–332
   Google Scholar
• Theofilopoulos A N, Prud'homrne GJ, Dixon FJ. Autoimmune aspects of systemic lupus erythematosus. Autoimmunity: basic concepts; systemic and selected organspecific diseases, JM Cruse, RE Lewis, Jr. Karger, Basel 1985; 190–218
   Google Scholar
• Schwartz R S, Stollar BD. Origins of anti-DNA antibodies. J Clin Invest 1985; 15: 321–321
   Google Scholar
• Harris E N, Asherson R A, Hughes G RV. Antiphospholipid antibodies-autoantibodies with a difference. Ann Rev Med 1988; 39: 261–271
   PubMedGoogle Scholar
• Winfield J B, Faiferman I, Kiffler D. Avidity of anti-DNA antibodies in serum and IgG glornerular eluates from patients with systemic lupus erythematosus. J Clin Invest 1977; 59: 90–96
   PubMed Web of Science ®Google Scholar
• Faaber P, Capel P J, Rikje P M, Vierwinden G, Van de Putte L BA, Koene R AP. Cross reactivity of anti-DNA antibodies with proteoglycans. Clin Exp Immunol 1984; 55: 502–508
   PubMed Web of Science ®Google Scholar
• Wight TN. Cell biology of arterial proteoglycans. Arteriosclerosis 1988; 9: 1–20
   Google Scholar
• Shimada K, Ozawa T. Evidence that cell surface heparan sulfate is involved in the high affinity thrombin binding to cultured porcine aortic endothelial cells. J Clin Invest 1985; 75: 1308–1316
   PubMedGoogle Scholar
• Marcum J A, Atha D H, Fritze L MS, Nawroth P, Stern D, Rosenberg R DR. Cloned bovine aortic endothelial cells synthesized anticoagulantly active heparan sulfate proteoglycan. J Biol Chem 1986; 261: 7507–7517
   PubMed Web of Science ®Google Scholar
• Kanwar YS. Biophysiology of glomerular filtration and proteinuria. Lab Invest 1984; 51: 7–21
   PubMed Web of Science ®Google Scholar
• Cotran R S, Rennke HG. Anionic sites and the mechanisms of proteinuria. N Engl J Med 1983; 309: 1050–1052
   PubMed Web of Science ®Google Scholar
• Nagy Z, Peters H, Huttner I. Charge related alterations of the cerebral endothelium. Lab Invest 1983; 49: 662–670
   PubMed Web of Science ®Google Scholar
• Fillit H M, Kemeny E, Luine V, Weksler M E, Zabriskie JB. Antivascular antibodies in the sera of patients with senile dementia-Alzheimer's type. J Geront 1987; 42: 180–184
   PubMedGoogle Scholar
• Makino H, Gibbons J T, Reddy M K, Kanwar YS. Nephritogenicity of antibodies to proteoglycans of the glomerular basement membrane-I. J Clin Invest 1986; 77: 142–156
   PubMed Web of Science ®Google Scholar
• Miettinen A, Stow J L, Mentone S, Farquhar MG. Antibodies to basement membrane heparan sulfate proteoglycan bind to the laminae rarae of the glomerular basement membrane (GBM) and induce subepithelial GBM thickening. J Exp Med 1986; 163: 1064–1084
   PubMed Web of Science ®Google Scholar
• Faaber P, Rijke T PM, Van de Putte L BA, Capel P JA, Berden J HM. Cross-reactivity of human and murine anti-DNA antibodies with heparan sulfate. The major glycocsoaminogly-can in glomerular basement membrane. J Clin Invest 1986; 77: 1824–1830
   PubMed Web of Science ®Google Scholar
• Fillit H, Damle S P, Gregory J D, Volin C, Poon-King T, Zabriskie J. Sera from patients with poststreptococcal glomerulonephritis contain antibodies to glomerular heparan sulfate proteoglycan. J Exp Med 1985; 161: 277–289
   PubMed Web of Science ®Google Scholar
• Tan E M, Cohens A S, Freis JF. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arth Rheum 1982; 25: 1271–1277
   PubMed Web of Science ®Google Scholar
• Kemeny E, Fillit H M, Damle S P, Kefalides N A, Mahabir R, Gregory J D, Antonovych T. Monoclonal antibodies to heparan sulfate proteoglycan: development and application to the study of normal tissue and pathologic human kidney biopsies. Conn Tiss Res 1988; 18: 9–25
   PubMed Web of Science ®Google Scholar
• Misra RP. Isolation of glomeruli from mammalian kidneys by graded sieving. Am J Clin Pathol 1972; 58: 135–139
   PubMed Web of Science ®Google Scholar
• Bitter T, Muir HM. A modified uronic acid carbazole reaction. Anal Biochem 1962; 4: 330–335
   PubMed Web of Science ®Google Scholar
• Kieras FJ. The linkage region of cartilage keratan sulfate to protein. J Bid Chem 1974; 249: 7506–7513
   PubMed Web of Science ®Google Scholar
• Schactevle G R, Pollack RL. A simple method for the quantitation of small amounts of protein in biologic material. Anal Biochem 1973; 51: 654–655
   PubMed Web of Science ®Google Scholar
• Blake M S, Johnston K H, Russell-Jones G J, Gotschlich EC. A rapid, sensitive method for detection of alkaline phosphatase conjugated anti-antibody on Western blots. Anal Biochem 1984; 136: 175–179
   PubMed Web of Science ®Google Scholar
• Koffler D, Carr R, Agnello V. Antibodies to polynucleotides in human sera: antigenic specificity and relation to disease. J Exp Med 1971; 134: 294–299
   PubMed Web of Science ®Google Scholar
• Mayer MM. Complement and complement fixation. Experimental Immunochemistry, EA Kabat, MM Mayer. C.C. Thomas, Springfield, Ill 1971; 133
   Google Scholar
• Linder E, Hormia M, Lehto V P, Tornroth T. Identification of cyytoskeletal intermediate filaments of vascular ndothelial cells as targets for autoantibodies in patient sera. Clin Immunol Immunopathol 1981; 21: 217–227
   PubMedGoogle Scholar
• Lindquist K J, Osterland CK. Human antibodies to vascular endothelium. Clin Exp Immunol 1971; 9: 753–760
   PubMedGoogle Scholar
• Shingu M, Hurd ER. Sera from patients with systemic lupus erythematosus reactive with human endothelial cells. J Rheumatol 1981; 8: 581–586
   PubMedGoogle Scholar
• Cines D B, Lyss A P, Reeber M, Bina M, DeHoratius R J. Presence of complement-binding anti-endothelial cell antibodies in systemic lupus erythematosus. J Clin Invest 1984; 13: 611–625
   Google Scholar
• Hughes G RV, Harris E N, Gharavi AE. The anticardiolipin syndrome. J Rheumatol 1986; 13: 486–489
   PubMed Web of Science ®Google Scholar
• Fillit H M, McCarty M, Blake M. Induction of antibodies to hyaluronic acid by immunization of rabbits with encapsulated streptococci. J Exp Med 1986; 164: 762–776
   PubMed Web of Science ®Google Scholar
• Kabat E A, Liao L, Sherman W H, Osserman EF. Immunochemical characterization of the specificities of two human monoclonal IgM's reacting with chondroitin sulfate. Carbohydr Res 1984; 130: 289–2970
   PubMedGoogle Scholar
• Jenkins R B, Hall T, Dorfman A. Chondroitin-6-sulfate ol-igosaccharides as immunological determinants of chick proteoglycans. J Bid Chem 1981; 256: 8279–8282
   PubMed Web of Science ®Google Scholar
• Fillit H M, Blake M, MacDonald C, McCarty M. Immunogenicity of liposome-bound hyaluronate in mice. At least two different antigenic sites on hyaluronate are identified by mouse monoclonal antibodies. J Exp Med 1988; 168: 971–982
   PubMedGoogle Scholar
• Lachman P J, Hughes-Jones NC. Initiation of complement activation. Complement, HJ Muller-Eberhard, PA Miescher. Springer-Verlag, New York 1985; 147–166
   Google Scholar
• Nossal G JV. Current concepts: Immunology: the basic components of the immune system. N Engl J Med 1987; 316: 1320–1325
   PubMed Web of Science ®Google Scholar
• Ellis S G, Verity MA. Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases, 1955–1977. Semin Arth Rheum 1979; 8: 212–221
   PubMed Web of Science ®Google Scholar
• Kushner M, Simonian N. Lupus anticoagulants, anticardiolipin antibodies, and cerebral ischemia. Stroke 1989; 20: 225–229
   PubMedGoogle Scholar
• Hardy J A, Mann D MA, Wester P, Winblad B. An integrative hypothesis concerning the pathogenesis and progression of Alzheimer's disease. Neurobiol Aging 1986; 7: 489–502
   PubMed Web of Science ®Google Scholar